You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mFOLFIRINOX

Showing 76 - 98 of 98
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Seoul (Bevacizumab + modified FOLFIRINOX)

Recruiting
  • Mucinous Ovarian Cancer
  • +2 more
  • Bevacizumab + modified FOLFIRINOX
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Dec 25, 2022

Pancreatic Cancer Trial in Seoul (Preoperative Stereotactic body radiation therapy (SBRT), Pancreatic resection, Adjuvant

Recruiting
  • Pancreatic Cancer
  • Preoperative Stereotactic body radiation therapy (SBRT), Pancreatic resection, Adjuvant Chemotherapy
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jan 10, 2023

Pancreatic Cancer Trial in New York (Biopsy, FOLFIRINOX, Ciprofloxacin)

Not yet recruiting
  • Pancreatic Cancer
  • Biopsy
  • +5 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 13, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Anyang, Seoul (NASOX)

Recruiting
  • Pancreatic Cancer
  • Pancreatic Ductal Adenocarcinoma
  • Anyang, Gyeonggi, Korea, Republic of
  • +1 more
Jul 16, 2021

Resectable Pancreatic Cancer Trial in Tianjin (AG Followed by FOLFIRINOX)

Recruiting
  • Resectable Pancreatic Cancer
  • AG Followed by FOLFIRINOX
  • Tianjin, Tianjin, China
    Rui Liu
Jan 8, 2023

Pancreatic Adenocarcinoma Resectable, Neoadjuvant Chemo Trial in Hangzhou (AG regimen, mFolfirinox)

Recruiting
  • Pancreatic Adenocarcinoma Resectable
  • Neoadjuvant Chemotherapy
  • AG regimen
  • mFolfirinox
  • Hangzhou, Zhejiang, China
    The second affiliated hospital of Zhejiang University
Nov 20, 2018

Metastatic Pancreatic Cancer Trial in Long Branch, New Brunswick (Folfirinox alternating with Gemcitabine-nab-Paclitaxel)

Recruiting
  • Metastatic Pancreatic Cancer
  • Folfirinox alternating with Gemcitabine-nab-Paclitaxel
  • Long Branch, New Jersey
  • +1 more
Jun 8, 2021

Pancreatic Cancer Trial in Houston (Oxaliplatin, Irinotecan, 5-FU)

Completed
Has Results
  • Pancreatic Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 24, 2020

Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New

Recruiting
  • Locally Advanced Rectal Carcinoma
  • +2 more
  • Gainesville, Florida
  • +1 more
Jan 4, 2023

Colon Cancer Stage III Trial in Daejeon (FOLFOXIRI, mFOLFOX 6)

Recruiting
  • Colon Cancer Stage III
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Dec 17, 2021

ADjuvant chemotherAPy After Curative Intent resecTion of

Recruiting
  • Ampullary Adenocarcinoma
  • Brescia, BS, Italy
    Fondazione Poliambulanza
Oct 3, 2023

Biliary Tract Cancer Trial in Busan (5-Fluorouracil, Leucovorin, Irinotecan)

Completed
  • Biliary Tract Cancer
  • Busan, Korea, Republic of
    Dong-A University Hospital
Feb 2, 2021

Metastatic Pancreatic Adenocarcinoma Trial in France (Arm A - Olaparib, ARM B - durvalumab plus selumetinib, ARM C FOLFIRI)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Arm A - Olaparib
  • +2 more
  • Avignon, France
  • +28 more
Dec 29, 2020

Borderline Resectable Pancreatic Cancer Trial in Pittsburgh (gemcitabine/nab-paclitaxel, mFOLFIRINOX)

Terminated
Has Results
  • Borderline Resectable Pancreatic Cancer
  • Pittsburgh, Pennsylvania
    Hillman Cancer Center
Jun 30, 2018

Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Houston (Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA),

Recruiting
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA)
  • Neoadjuvant chemotherapy (NAC)
  • Houston, Texas
    Memorial Hermann Hospital
Sep 20, 2021

High Risk Localised Pancreatic Cancer Trial in St Leonards (Stereotactic Body Radiotherapy (SBRT))

Recruiting
  • High Risk Localised Pancreatic Cancer
  • Stereotactic Body Radiotherapy (SBRT)
  • St Leonards, New South Wales, Australia
    Royal North Shore Hospital
May 26, 2021

Pancreatic Adenocarcinoma Trial in Seoul (Preoperative modified FOLFIRINOX and postoperative gemcitabine)

Completed
  • Pancreatic Adenocarcinoma
  • Preoperative modified FOLFIRINOX and postoperative gemcitabine
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Nov 22, 2019

Locally Advanced Gastric Adenocarcinoma Trial in Tianjin (PD-1 antibody combined with FOLFIRINOX regimen, PD-1 antibody combined

Recruiting
  • Locally Advanced Gastric Adenocarcinoma
  • PD-1 antibody combined with FOLFIRINOX regimen
  • PD-1 antibody combined with SOX program
  • Tianjin, Tianjin, China
    RuiLiu
May 27, 2021

Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese

Completed
  • Pancreatic Cancer
  • +2 more
  • Hangzhou, Zhejiang, China
    the second affiliated hospital of Zhejiang University
Mar 25, 2018

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • La Jolla, California
  • +13 more
Aug 30, 2018

Pancreatic Adenocarcinoma Metastatic, Chemo Effect Trial in Hangzhou (Sequential Treatment)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • Chemotherapy Effect
  • Sequential Treatment
  • Hangzhou, Zhejiang, China
    The second affiliated hospital of Zhejiang University
Aug 20, 2018

Pancreatic Cancer Trial (biological, drug, other)

Withdrawn
  • Pancreatic Cancer
  • ganitumab
  • +6 more
  • (no location specified)
Jun 27, 2016

Colon Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Buffalo (Fluorouracil, Irinotecan

Withdrawn
  • Colon Adenocarcinoma
  • +16 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 19, 2016